{"id":9954,"date":"2026-09-14T14:55:43","date_gmt":"2026-09-14T14:55:43","guid":{"rendered":"https:\/\/godshand.link\/ground_post\/report-of-the-joint-meeting-of-acsomp-and-gacvs-june-2026\/"},"modified":"2026-09-14T14:55:43","modified_gmt":"2026-09-14T14:55:43","slug":"report-of-the-joint-meeting-of-acsomp-and-gacvs-june-2026","status":"publish","type":"ground_post","link":"https:\/\/godshand.link\/en_gb\/ground_post\/report-of-the-joint-meeting-of-acsomp-and-gacvs-june-2026\/","title":{"rendered":"Report of the joint meeting of ACSoMP and GACVS June 2026"},"content":{"rendered":"<p><br \/>\n<\/p>\n<section class=\"dynamic-content__section dynamic-content__container\">\n<div class=\"dynamic-content__section-container\">\n<div class=\"dynamic-content__figure-container\">\n<figure class=\"dynamic-content__figure\">\n      <img decoding=\"async\" src=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/c8d889c0-4ebe-408d-9260-808aa4e0f616\/content\" alt=\"Report of the joint meeting of ACSoMP and GACVS June 2026\"><br \/>\n     <\/figure>\n<div class=\"button button-blue-background\"><a target=\"_blank\" href=\"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/df6a76ba-7448-409a-baa2-2fea523e0cc8\/content\" onclick=\"sendGaEvent('Download','https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/df6a76ba-7448-409a-baa2-2fea523e0cc8\/content')\">Download <span>(864.4 kB)<\/span><\/a><\/div><\/div>\n<div class=\"dynamic-content__description-container\">\n<div class=\"row\">\n<div class=\"col-md-8\">\n<div class=\"dynamic-content__description\">\n<h3>Overview <\/h3>\n<p><!--StartFragment-->The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999, and the Advisory Committee on Safety of Medicinal Products (ACSoMP) was established in 2003, to provide independent, authoritative scientific advice to WHO on issues of vaccine and medicine safety of global or regional concern. The 4-day hybrid meeting of ACSoMP and GACVS, held on 23-26 June 2026, included topics specific to vaccine safety, pharmacovigilance issues common to both vaccines and medicines and topics specific to medicines safety. A summary of the discussions and recommendations related to vaccine safety and sessions of common interest for pharmacovigilance of both medicines and vaccines are provided here.<!--EndFragment-->\n      <\/div><\/div>\n<div class=\"col-md-4\">\n<div class=\"dynamic-content__details\">\n<div class=\"detail who-team\">\n<div class=\"label\">WHO Team<\/div>\n<div class=\"value\">\n                 <span><br \/>\nRegulation and Prequalification (RPQ)                 <\/span>\n         <\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Editors<\/div>\n<div class=\"value\">World Health Organization<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Number of pages<\/div>\n<div class=\"value\">6<\/div><\/div>\n<div class=\"detail\">\n<div class=\"label\">Reference numbers<\/div>\n<div class=\"value\">\n<div><strong class=\"label-sm\">WHO Reference Number: <\/strong><span>Weekly Epidemiological Record, 101(34): 187 &#8211; 192<\/span><\/div><\/div><\/div><\/div><\/div><\/div><\/div><\/div>\n<\/section>\n<p><br \/>\n<br \/><a href=\"https:\/\/www.who.int\/publications\/i\/item\/report-of-the-joint-meeting-of-acsomp-and-gacvs-june-2026?rand=6398\" target=\"_blank\">Source link <\/a><\/p>","protected":false},"excerpt":{"rendered":"<p>Download (864.4 kB) Overview The Global Advisory Committee on Vaccine Safety (GACVS) was established in 1999, and the Advisory Committee on Safety of Medicinal Products (ACSoMP) was established in 2003, to provide independent, authoritative scientific advice to WHO on issues of vaccine and medicine safety of global or regional concern. The 4-day hybrid meeting of ACSoMP and GACVS, held on&hellip;<\/p>","protected":false},"author":99035,"featured_media":9955,"parent":0,"menu_order":0,"comment_status":"open","ping_status":"open","template":"","format":"standard","meta":{"give_campaign_id":0,"footnotes":""},"tags":[3294,3295,650,847,452,687],"ground_category":[315,316],"class_list":["post-9954","ground_post","type-ground_post","status-publish","format-standard","has-post-thumbnail","hentry","tag-acsomp","tag-gacvs","tag-joint","tag-june","tag-meeting","tag-report","ground_category-2-grounds-tribulation","ground_category-2-1-time-disease"],"fifu_image_url":"https:\/\/iris.who.int\/server\/api\/core\/bitstreams\/c8d889c0-4ebe-408d-9260-808aa4e0f616\/content","_links":{"self":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9954","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post"}],"about":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/types\/ground_post"}],"author":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/users\/99035"}],"replies":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/comments?post=9954"}],"version-history":[{"count":0,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_post\/9954\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media\/9955"}],"wp:attachment":[{"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/media?parent=9954"}],"wp:term":[{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/tags?post=9954"},{"taxonomy":"ground_category","embeddable":true,"href":"https:\/\/godshand.link\/en_gb\/wp-json\/wp\/v2\/ground_category?post=9954"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}